Health-related quality of life among children with acute lymphoblastic leukemia
Pediatric Blood & Cancer, 04/27/2012Furlong W et al.
Patients with acute lymphoblastic leukemia (ALL) experienced important but declining deficits in health–related quality of life (HRQL) during active treatment phases: Equivalent to losing approximately 2 months of life in perfect health. HRQL within the 2–years post–treatment phase was similar to controls. The policy challenge is to develop new treatment protocols producing fewer disabilities in mobility/ambulation, emotion, self–care, and pain without compromising survival.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.